Surfactant protein A and lamellar bodies: A homologous secretory function of peritoneum, synovium, and lung

Peritoneal Dialysis International

Volumn 16, Issue 6, 1996, Pages 574-581

  Dobbie, James W ^a  

^a University Department of Surgery   (United Kingdom)

Author keywords

Lamellar bodies; Lung; Peritoneum; Surfactant protein A; Synovium

Indexed keywords

AUTOANTIGEN; GLYCOPROTEIN; HEAT SHOCK PROTEIN; LUNG SURFACTANT; PROTEOLIPID; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A;

BODY FLUID; CELL ORGANELLE; CHEMISTRY; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; PERITONEUM; REVIEW; RHEUMATIC DISEASE; SECRETION; SYNOVIUM; ULTRASTRUCTURE;

AUTOANTIGENS; BODY FLUIDS; GLYCOPROTEINS; HEAT-SHOCK PROTEINS; HUMANS; LUNG; ORGANELLES; PERITONEUM; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RHEUMATIC DISEASES; SYNOVIAL MEMBRANE;

EID: 0030278241     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dobbie JW. From philosopher to fish: the comparative anatomy of the peritoneal cavity as an excretory organ and its significance for peritoneal dialysis in man.Perit Dial Int 1988; 8:3-6.
2. Stratton CJ. Multilamellar body formation in mammalian lung: an ultrastructural study utilizing three lipid-retention procedures. J Ultrastruct Res 1975; 52:309-20.
3. Futaesaku Y, Mizukira V, Nakamura H. A new fixation method using tannic acid for electron microscopy and some observations of biological specimens. J Histochem Cytochem 1972; 4:155-7.
4. Kalina M, Pease DC. The preservation of ultrastructure in saturated phosphatidylcholines by tannic acid in model systems and type II pneumocytes. J Cell Biol 1977; 74:726-41.
5. Stratton CJ. Morphology of surfactant producing cells and of the alveolar lining layer. In: Robertson B, Van Golde LMG, Batenburg JJ, eds. Pulmonary surfactant. Amsterdam: Elsevier, 1984:67-118.
6. Rooney SA. Phospholipid composition, biosynthesis and secretion. In: Parent RA, ed. Comparative biology of the normal lung. Boca Raton: CRC Press, 1992:511-44.
7. Williams MC. Conversion of lamellar body membranes into tubular myelin in alveoli of fetal rat lungs. J Cell Biol 1977; 72:260-77.
8. King RJ, Clements JA. Surface active materials from dog lung. II. Composition and physiological correlations. Am J Physiol 1972; 223:715-26.
9. Hawgood S, Clements JA. Pulmonary surfactant and its apoproteins. J Clin Invest 1990; 86:1-6.
10. Hallman MB, Epstein L, Gluck L. Analysis of labeling and clearance of lung surfactant phospholipids in rabbit: evidence of bi-directional surfactant flux between lamellar bodies and alveolar lavage. J Clin Invest 1981; 68:742-51.
11. Jacobs H, Jobe A, Ikegami M, Conaway D. The significance of re-utilization of surfactant phosphatidylcholine. J Biol Chem 1983; 258:4156-65.
12. White RT, Damm D, Miller J, et al. Isolation and characterisation of the human pulmonary surfactant apoprotein gene. Nature 1985; 317:361-3.
13. Floros J, Steinbrink R, Jacobs K, et al. Isolation and characterisation of cDNA clones for the 35-kDa pulmonary surfactant-associated protein. J Biol Chem 1986; 261:9029-33.
14. King RJ, Simon D, Horowitz PM. Aspects of secondary and quaternary structure of surfactant protein A from canine lung. Biochim Biophys Acta 1989; 1001:294-301.
15. O'Reilly MA, Nogee L, Whitsett JA. Requirement of the collagenous domain for carbohydrate processing and secretion of a surfactant protein, SP-A.Biochim Biophys Acta 1988; 969:176-84.
16. Suzuki Y, Fujita Y, Kogishi K. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant An Rev Respir Dis 1989; 140:75-81.
17. Dobbie JW, Zaki MA, Wilson LS. Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 1981; 26:213-23.
18. Dobbie JW, Zaki MA. The ultrastructure of the parietal peritoneum in normal and uremic man and in patients on CAPD. In: Maher JF, Winchester JF, eds. Frontiers in peritoneal dilysis. New York: Field, Rich and Assoc. Inc., 1986:105-7.
19. Dobbie JW. New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis.Am J Kidney Dis 1990; 15:97-109.
20. Grahame GR, Torchia MC, Dankewich KA, et al. Surface active material in peritoneal effluent of CAPD patients. Perit Dial Bull 1985; 5:109-11.
21. Dobbie JW, Pavlina T, Lloyd J, Johnson R. Phosphatidylcholine synthesis by peritoneal mesothelium. Its implications for peritoneal dialysis. Am J Kidney Dis 1988; 12:31-6.
22. Dobbie JW. Ultrastructural similarities between mesothelium and type II pneumocytes and their relevance to phospholipid surfactant production by the peritoneum. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in continuous ambulatory peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1988; 4:32-41.
23. Dobbie JW, Lloyd JK. Mesothelium secretes lamellar bodies in a similar manner to type II pneumocyte secretion of surfactant. Perit Dial Int 1989; 9:215-21.
24. Dobbie JW, Tasiaux N, Meijers P, et al. Lamellar bodies in synoviocytes, mesothelium and specific epithelia as possible site of auto-antigen in rheumatoid disease. Br J Rheumatol 1994; 33:508-19.
25. Dobbie JW, Hind C, Meijers P, et al. Lamellar body secretion: ultrastructural analysis of an unexplored function of synoviocytes. Br J Rheumatol 1995; 34:13-23.
26. Zasadzinski JAN, Stratton CJ, Rudolph R. Lung lamellar body amphiphilic topography: a morphological evaluation using the continuum theory of liquid crystals. Anat Rec 1988; 221:520-32.
27. Maxwell JC. On the cyclide.Q J Pure Applied Math 1868; 9:111-26.
28. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994; 8:957-67.
29. Miles PR, Ma JYC, Bowman L. Degradation of pulmonary surfactant desaturated phosphatidylcholines by alveolar macrophages. J Appl Physiol 1988; 64:2474-81.
30. Revell PA. Synovial lining cells. Rheumatol Int 1989; 9:49-51.
31. Bauer W, Clark WS. The systemic manifestations of rheumatoid arthritis.Trans Assoc Am Physicians 1948; 61:339-43.
32. Ellman P, Ball RE. "Rheumatoid disease" with joint and pulmonary manifestations. BMJ 1948; 11:816-20.
33. Venables PJW. Infection and rheumatoid arthritis. Curr Opin Rheumatol 1989; 1:15-20.
34. Rook GAW, Stanford JL. Slow bacterial infections or autoimmunity? Immunol Today 1992; 13:160-4.
35. Silman AJ. Is rheumatoid arthritis an infectious disease? BMJ 1991; 303:200-1.
36. Holoshitz J, Matitiau A, Cohen IR. Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II.J Clin Invest 1984; 73:211-15.
37. van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans.Proc Natl Acad Sci US A1985; 82:5117-20.
38. van Eden W, Thole JER, Van der Zee R, et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988; 331:171-3.
39. Holoshitz J, Klajman A, Drucker I, et al. T-lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet 1986; 2:305-9.
40. Pope RM, Lovis RM, Gupta RS. Activation of synovial fluid T lymphocytes by 60-kD heat-shock proteins in patients with inflammatory synovitis. Nephritis Rheumatism 1992; 35:43-8.
41. de Graeff-Meeder ER, Voorhorst M, van Eden W, et al. Antibodies to the mycobacterial 65-kD heat shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am J Pathol 1990; 137:1013-17.
42. Kleinau S, Soderstrom K, Kiessling R, Klareskog L. A monoclonal antibody to the mycobacterial 65kDa heat shock protein (ML30) binds to cells in normal and arthritic joints of rats. Scand J Immunol 1991; 33:192-202.
43. Gaston JSH. Auto-antigens in rheumatoid arthritis - a new candidate. Br J Rheumatol 1994; 33:505-7.